ANKRD20A3P

Across TCGA pan-cancer cohorts, ANKRD20A3P RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated ANKRD20A3P data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher ANKRD20A3P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated ANKRD20A3P expression acts as an unfavorable survival marker, although some lineages such as CESC and THYM show a favorable association.

ACC, COAD, and LUSC are the cancer types where ANKRD20A3P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	OS	Tertile	All	0.207	0.775	<.001	84	view →
COAD	DFS	Tertile	IV	0.159	0.503	.006	45	view →
LUSC	OS	Tertile	III,IV	0.353	0.611	.011	36	view →
KICH	OS	Tertile	III,IV	0.178	0.847	<.001	18	view →
MESO	OS	Tertile	IV	0.077	0.592	.019	18	view →
LGG	OS	Median	All	0.755	0.846	.010	13	view →
CESC	DFS	Tertile	All	0.715	0.497	.037	12	view →
SCLC	DFS	Quartile	II,III,IV	0.484	1.000	.024	4	view →
THYM	DFS	Tertile	All	1.000	0.882	.049	3	view →
GBM	OS	Quartile	All	0.508	0.379	.048	1	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

ANKRD20A3P–ACC (OS)

Open the ACC breakdown →